QQ客服 官方微博 反馈留言

浏览/检索结果: 共12条，第1-10条 帮助 限定条件 专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文 THORACIC CANCER, 2022 作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo 收藏  |  浏览/下载：34/0  |  提交时间：2022/12/23 checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects   Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文 THORACIC CANCER, 2022 作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo 收藏  |  浏览/下载：41/0  |  提交时间：2022/12/22 fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase   A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Lu, S.;  Zhang, Y.;  Zhang, G.;  Zhou, J.;  Cang, S. 收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23 third-generation EGFR-TKI  befotertinib  T790M   Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial 期刊论文 BMC MEDICINE, 2022, 卷号: 20 作者:  Song, Zhengbo;  Lou, Guangyuan;  Wang, Yina;  Yang, Zhiping;  Wang, Wenxian 收藏  |  浏览/下载：17/0  |  提交时间：2022/12/23 Thymic epithelial tumors  Apatinib  Efficacy  Toxicities   Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements 期刊论文 NPJ PRECISION ONCOLOGY, 2022, 卷号: 6 作者:  Zhang, Yongchang;  Huang, Zhe;  Zeng, Liang;  Zhang, Xiangyu;  Li, Yizhi 收藏  |  浏览/下载：21/0  |  提交时间：2022/05/05 D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156). 期刊论文 CANCER RESEARCH, 2021, 卷号: 81 作者:  Lu, Shun;  Zhang, Yiping;  Zhang, Guojun;  Zhou, Jianying;  Cang, Shundong 收藏  |  浏览/下载：60/0  |  提交时间：2021/11/01 Safety and efficacy of apatinib as third or later line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma: A post-marketing phase IV study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying 收藏  |  浏览/下载：24/0  |  提交时间：2022/01/10 Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Li, Jin;  Qin, Shukui;  Wen, Lu;  Wang, Junsheng;  Deng, Wenying 收藏  |  浏览/下载：33/0  |  提交时间：2022/01/10 A Randomized Study Comparing Cisplatin/Paclitaxel Liposome vs Cisplatin/Gemcitabine in Chemonaive, Advanced Squamous NSCLC 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16 作者:  Zhou, C.;  Jiang, L.;  Dong, X.;  Gu, K.;  Pan, Y. 收藏  |  浏览/下载：60/0  |  提交时间：2021/05/17 gemcitabine  advanced squamous NSCLC  Paclitaxel liposome   A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancer 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 卷号: 10 作者:  Zhu, Zhihua;  Song, Zhengbo;  Jiao, Wenjie;  Mei, Weijian;  Xu, Chunwei 收藏  |  浏览/下载：58/0  |  提交时间：2021/05/17 Non-small cell lung cancer (NSCLC)  examined lymph node (ELN)  minimal number  nodal staging  cohort study